March 19, 2024

Human MLH1(MutL Homolog 1) ELISA Kit

Human MLH1(MutL Homolog 1) ELISA Kit

To Order Contact us: michael@lotusbiotechnologies.com

Human MutL Homolog 1 (MLH1) ELISA Kit

EKU06045-5x96T Biomatik Corporation 5x96T 3770.55 EUR

Human MutL Homolog 1 (MLH1) ELISA Kit

EKU06045-96T Biomatik Corporation 96T 793.8 EUR

Human MutL Homolog 1 (MLH1) ELISA Kit

EKN47156-48T Biomatik Corporation 48T 378.7 EUR

Human MutL Homolog 1 (MLH1) ELISA Kit

EKN47156-5x96T Biomatik Corporation 5x96T 2569.75 EUR

Human MutL Homolog 1 (MLH1) ELISA Kit

EKN47156-96T Biomatik Corporation 96T 541 EUR

Human MutL Homolog 1 (MLH1) ELISA Kit

RD-MLH1-Hu-48Tests Reddot Biotech 48 Tests 625.2 EUR

Human MutL Homolog 1 (MLH1) ELISA Kit

RD-MLH1-Hu-96Tests Reddot Biotech 96 Tests 867.6 EUR

Human MutL Homolog 1 (MLH1) ELISA Kit

RDR-MLH1-Hu-48Tests Reddot Biotech 48 Tests 652.8 EUR

Human MutL Homolog 1 (MLH1) ELISA Kit

RDR-MLH1-Hu-96Tests Reddot Biotech 96 Tests 907.2 EUR

Human MutL Homolog 1 (MLH1) ELISA Kit

DL-MLH1-Hu DL Develop 96T 441 EUR
Description: tissue homogenates, cell lysates or other biological fluids.

Human MutL Homolog 1 (MLH1) ELISA Kit

DLR-MLH1-Hu DL Develop 96T 463 EUR
Description: tissue homogenates, cell lysates or other biological fluids.

Human MutL Homolog 1 (MLH1) ELISA Kit

SEJ742Hu-10x96wellstestplate Cloud-Clone 10x96-wells test plate 5677.8 EUR
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human MutL Homolog 1 (MLH1) in tissue homogenates, cell lysates and other biological fluids.

Human MutL Homolog 1 (MLH1) ELISA Kit

SEJ742Hu-1x96wellstestplate Cloud-Clone 1x96-wells test plate 766.8 EUR
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human MutL Homolog 1 (MLH1) in tissue homogenates, cell lysates and other biological fluids.

Human MutL Homolog 1 (MLH1) ELISA Kit

RDR-MLH1-Hu-48T Reddot Biotech 48T 475.34 EUR
Description: tissue homogenates, cell lysates and other biological fluids.

Human MutL Homolog 1 (MLH1) ELISA Kit

RDR-MLH1-Hu-96T Reddot Biotech 96T 679.04 EUR
Description: tissue homogenates, cell lysates and other biological fluids.

Human MutL Homolog 1 (MLH1) ELISA Kit

RD-MLH1-Hu-48T Reddot Biotech 48T 452.7 EUR
Description: tissue homogenates, cell lysates and other biological fluids.

Human MutL Homolog 1 (MLH1) ELISA Kit

RD-MLH1-Hu-96T Reddot Biotech 96T 646.7 EUR
Description: tissue homogenates, cell lysates and other biological fluids.

ELISA kit for Human MLH1 (MutL Homolog 1)

ELK4307 ELK Biotech 1 plate of 96 wells 518.4 EUR
Description: A sandwich ELISA kit for detection of MutL Homolog 1 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

ELISA Kit for MutL Homolog 1 (MLH1)

SEJ742Hu Cloud-Clone 96Т 700 EUR

MLH1 (MutL Homolog 1)

MO47010 Neuromics 100 ul 418.8 EUR

Human MutL Homolog 1 (MLH1) CLIA Kit

20-abx495774 Abbexa
  • 9567.60 EUR
  • 5095.20 EUR
  • 1177.20 EUR
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human MutL Homolog 1 (MLH1) Protein

20-abx654421 Abbexa
  • 693.60 EUR
  • 309.60 EUR
  • 2064.00 EUR
  • 828.00 EUR
  • 510.00 EUR
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

MLH1 (MutL Homolog 1)(MLH1/1324), 0.2mg/mL

BNUB1324-100 Biotium 1uL 225 EUR
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

MLH1 (MutL Homolog 1)(MLH1/1324), 0.2mg/mL

BNUB1324-500 Biotium 1uL 485 EUR
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

MLH1 (MutL Homolog 1)(MLH1/1324), 1mg/mL

BNUM1324-50 Biotium 1uL 396 EUR
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

MutL Homolog 1 (MLH1) Antibody

20-abx317973 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

MutL Homolog 1 (MLH1) Antibody

20-abx241566 Abbexa
  • 493.20 EUR
  • 360.00 EUR
  • 100 ul
  • 50 ul

MutL Homolog 1 (MLH1) Antibody

20-abx241567 Abbexa
  • 493.20 EUR
  • 360.00 EUR
  • 100 ul
  • 50 ul

MutL Homolog 1 (MLH1) Antibody

abx235213-100ug Abbexa 100 ug 577.2 EUR

MutL Homolog 1 (MLH1) Antibody

20-abx173641 Abbexa
  • 1028.40 EUR
  • 526.80 EUR
  • 1 mg
  • 200 ug

MutL Homolog 1 (MLH1) Antibody

20-abx177638 Abbexa
  • 1446.00 EUR
  • 693.60 EUR
  • 1 mg
  • 200 ug

MutL Homolog 1 (MLH1) Antibody

20-abx113897 Abbexa
  • 878.40 EUR
  • 477.60 EUR
  • 150 ul
  • 50 ul

MutL Homolog 1 (MLH1) Antibody

abx026385-400ul Abbexa 400 ul 627.6 EUR

MutL Homolog 1 (MLH1) Antibody

abx026385-80l Abbexa 80 µl 343.2 EUR

MutL Homolog 1 (MLH1) Antibody

abx025515-100ul Abbexa 100 ul 627.6 EUR

MutL Homolog 1 (MLH1) Antibody

20-abx014046 Abbexa
  • 376.80 EUR
  • 117.60 EUR
  • 477.60 EUR
  • 142.80 EUR
  • 594.00 EUR
  • 100 ug
  • 10 ug
  • 200 ug
  • 20 ug
  • 300 µg

MutL Homolog 1 (MLH1) Antibody

20-abx328114 Abbexa
  • 376.80 EUR
  • 292.80 EUR
  • 100 ug
  • 50 ug

MutL Homolog 1 (MLH1) Antibody

20-abx002899 Abbexa
  • 493.20 EUR
  • 710.40 EUR
  • 100 ul
  • 200 ul

MutL Homolog 1 (MLH1) Antibody

20-abx008989 Abbexa
  • 360.00 EUR
  • 526.80 EUR
  • 226.80 EUR
  • 100 ul
  • 200 ul
  • 30 ul

MutL Homolog 1 (MLH1) Antibody

20-abx000639 Abbexa
  • 493.20 EUR
  • 710.40 EUR
  • 218.40 EUR
  • 376.80 EUR
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

MutL Homolog 1 (MLH1) Antibody

abx012221-100ul Abbexa 100 ul 493.2 EUR

MLH1 Antibody / MutL Homolog 1

V8749-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis.

MLH1 Antibody / MutL Homolog 1

V8749-20UG NSJ Bioreagents 20 ug 153.3 EUR
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis.

MLH1 Antibody / MutL Homolog 1

V8749SAF-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis.

MLH1 Antibody / MutL Homolog 1

V9166-100UG NSJ Bioreagents 100ug 349.3 EUR
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis.

MLH1 Antibody / MutL Homolog 1

V9166-20UG NSJ Bioreagents 20ug 153.3 EUR
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis.

MLH1 Antibody / MutL Homolog 1

V9166SAF-100UG NSJ Bioreagents 100ug 349.3 EUR
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis.

MLH1 Antibody / MutL Homolog 1

V9349-100UG NSJ Bioreagents 100ug 349.3 EUR
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis.

MLH1 Antibody / MutL Homolog 1

V9349-20UG NSJ Bioreagents 20ug 153.3 EUR
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis.

MLH1 Antibody / MutL Homolog 1

V9349SAF-100UG NSJ Bioreagents 100ug 349.3 EUR
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis.

MLH1 Antibody / MutL Homolog 1

V4038-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis.

MLH1 Antibody / MutL Homolog 1

V4038-20UG NSJ Bioreagents 20 ug 153.3 EUR
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis.

MLH1 Antibody / MutL Homolog 1

V4038SAF-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis.

Human MLH3(MutL Homolog 3) ELISA Kit

ELK7522-48T ELK Biotech 48T Ask for price
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human MLH3. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human MLH3. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human MLH3, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human MLH3 in the samples is then determined by comparing the OD of the samples to the standard curve.

Human MLH3(MutL Homolog 3) ELISA Kit

ELK7522-96T ELK Biotech 96T Ask for price
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human MLH3. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human MLH3. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human MLH3, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human MLH3 in the samples is then determined by comparing the OD of the samples to the standard curve.

MutL Homolog 1 (MLH1) Antibody (HRP)

20-abx313263 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

MutL Homolog 1 (MLH1) Antibody (FITC)

20-abx313264 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

MutL Homolog 1 (MLH1) Antibody (Biotin)

20-abx313265 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

MLH1 (MutL Homolog 1)(MLH1/1324), CF647 conjugate, 0.1mg/mL

BNC471324-100 Biotium 1uL 192 EUR
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

MLH1 (MutL Homolog 1)(MLH1/1324), CF647 conjugate, 0.1mg/mL

BNC471324-500 Biotium 1uL 532 EUR
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

MLH1 (MutL Homolog 1)(MLH1/1324), CF568 conjugate, 0.1mg/mL

BNC681324-100 Biotium 1uL 192 EUR
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

MLH1 (MutL Homolog 1)(MLH1/1324), CF568 conjugate, 0.1mg/mL

BNC681324-500 Biotium 1uL 532 EUR
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

MLH1 (MutL Homolog 1)(MLH1/1324), CF594 conjugate, 0.1mg/mL

BNC941324-100 Biotium 1uL 192 EUR
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

MLH1 (MutL Homolog 1)(MLH1/1324), CF594 conjugate, 0.1mg/mL

BNC941324-500 Biotium 1uL 532 EUR
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

MLH1 (MutL Homolog 1)(MLH1/1324), CF640R conjugate, 0.1mg/mL

BNC401324-100 Biotium 1uL 192 EUR
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

MLH1 (MutL Homolog 1)(MLH1/1324), CF640R conjugate, 0.1mg/mL

BNC401324-500 Biotium 1uL 532 EUR
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

MLH1 (MutL Homolog 1)(MLH1/1324), CF488A conjugate, 0.1mg/mL

BNC881324-100 Biotium 1uL 192 EUR
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

MLH1 (MutL Homolog 1)(MLH1/1324), CF488A conjugate, 0.1mg/mL

BNC881324-500 Biotium 1uL 532 EUR
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

MLH1 (MutL Homolog 1)(MLH1/1324), CF405S conjugate, 0.1mg/mL

BNC041324-100 Biotium 1uL 192 EUR
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

MLH1 (MutL Homolog 1)(MLH1/1324), CF405S conjugate, 0.1mg/mL

BNC041324-500 Biotium 1uL 532 EUR
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

MLH1 (MutL Homolog 1)(MLH1/1324), Biotin conjugate, 0.1mg/mL

BNCB1324-100 Biotium 1uL 192 EUR
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

MLH1 (MutL Homolog 1)(MLH1/1324), Biotin conjugate, 0.1mg/mL

BNCB1324-500 Biotium 1uL 532 EUR
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Human MutL Homolog 3 (MLH3) ELISA Kit

20-abx258180 Abbexa
  • 8853.60 EUR
  • 4719.60 EUR
  • 1093.20 EUR
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human MutL Homolog 3 (MLH3) ELISA Kit

SEL736Hu-10x96wellstestplate Cloud-Clone 10x96-wells test plate 6227.58 EUR
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human MutL Homolog 3 (MLH3) in Tissue homogenates, cell lysates and other biological fluids.

Human MutL Homolog 3 (MLH3) ELISA Kit

SEL736Hu-1x48wellstestplate Cloud-Clone 1x48-wells test plate 618.04 EUR
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human MutL Homolog 3 (MLH3) in Tissue homogenates, cell lysates and other biological fluids.

Human MutL Homolog 3 (MLH3) ELISA Kit

SEL736Hu-1x96wellstestplate Cloud-Clone 1x96-wells test plate 831.48 EUR
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human MutL Homolog 3 (MLH3) in Tissue homogenates, cell lysates and other biological fluids.

Human MutL Homolog 3 (MLH3) ELISA Kit

SEL736Hu-5x96wellstestplate Cloud-Clone 5x96-wells test plate 3381.66 EUR
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human MutL Homolog 3 (MLH3) in Tissue homogenates, cell lysates and other biological fluids.

Human MutL Homolog 3 (MLH3) ELISA Kit

4-SEL736Hu Cloud-Clone
  • 6288.00 EUR
  • 3322.80 EUR
  • 831.60 EUR
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human MutL Homolog 3 (MLH3) in samples from Tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species.

Human MutL Homolog 3 (MLH3) ELISA Kit

EKN50428-48T Biomatik Corporation 48T 380.31 EUR

Human MutL Homolog 3 (MLH3) ELISA Kit

EKN50428-5x96T Biomatik Corporation 5x96T 2580.68 EUR

Human MutL Homolog 3 (MLH3) ELISA Kit

EKN50428-96T Biomatik Corporation 96T 543.3 EUR

Human MutL Homolog 3 (MLH3) ELISA Kit

EKU09317-48T Biomatik Corporation 48T 610.82 EUR

Human MutL Homolog 3 (MLH3) ELISA Kit

EKU09317-5x96T Biomatik Corporation 5x96T 4144.85 EUR

Human MutL Homolog 3 (MLH3) ELISA Kit

EKU09317-96T Biomatik Corporation 96T 872.6 EUR

MutL Homolog 1 (MLH1) Magnetic Luminex Assay Kit

LKU606804-96T Biomatik Corporation 96T 966 EUR

ELISA kit for Human MLH3 (MutL Homolog 3)

ELK7522 ELK Biotech 1 plate of 96 wells 518.4 EUR
Description: A sandwich ELISA kit for detection of MutL Homolog 3 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Mlh1 (GFP-tagged) - Mouse mutL homolog 1 (E. coli) (Mlh1)

MG210511 Origene Technologies GmbH 10 µg Ask for price

Mlh1 (untagged) - Mouse mutL homolog 1 (E. coli) (Mlh1), (10ug)

MC221356 Origene Technologies GmbH 10 µg Ask for price

Mlh1 (Myc-DDK-tagged) - Mouse mutL homolog 1 (E. coli) (Mlh1)

MR210511 Origene Technologies GmbH 10 µg Ask for price

MutL Protein Homolog 1 (MLH1) (ABT-MLH1) Mouse mAb

E2251305 EnoGene 100ul 225 EUR
Description: Available in various conjugation types.

Mlh1 (untagged ORF) - Rat mutL homolog 1 (E. coli) (Mlh1), (10 ug)

RN207442 Origene Technologies GmbH 10 µg Ask for price

MLH1 (untagged) - Homo sapiens mutL homolog 1 (MLH1), transcript variant 5

SC330648 Origene Technologies GmbH 10 µg Ask for price

MLH1 (untagged) - Homo sapiens mutL homolog 1 (MLH1), transcript variant 6

SC330650 Origene Technologies GmbH 10 µg Ask for price

MLH1 (untagged) - Homo sapiens mutL homolog 1 (MLH1), transcript variant 7

SC330651 Origene Technologies GmbH 10 µg Ask for price

MLH1 (GFP-tagged) - Homo sapiens mutL homolog 1 (MLH1), transcript variant 6

RG232898 Origene Technologies GmbH 10 µg Ask for price

MLH1 (GFP-tagged) - Homo sapiens mutL homolog 1 (MLH1), transcript variant 7

RG232899 Origene Technologies GmbH 10 µg Ask for price

MLH1 (GFP-tagged) - Homo sapiens mutL homolog 1 (MLH1), transcript variant 5

RG233081 Origene Technologies GmbH 10 µg Ask for price

Mlh1 (Myc-DDK-tagged ORF) - Rat mutL homolog 1 (E. coli) (Mlh1), (10 ug)

RR207442 Origene Technologies GmbH 10 µg Ask for price

MLH1 (Myc-DDK tagged) - Homo sapiens mutL homolog 1 (MLH1), transcript variant 6

RC232898 Origene Technologies GmbH 10 µg Ask for price

MLH1 (Myc-DDK tagged) - Homo sapiens mutL homolog 1 (MLH1), transcript variant 7

RC232899 Origene Technologies GmbH 10 µg Ask for price

MLH1 (Myc-DDK tagged) - Homo sapiens mutL homolog 1 (MLH1), transcript variant 5

RC233081 Origene Technologies GmbH 10 µg Ask for price

Lenti ORF clone of Mlh1 (mGFP-tagged) - Mouse mutL homolog 1 (E. coli) (Mlh1)

MR210511L4 Origene Technologies GmbH 10 µg Ask for price

Human MutL Homolog 3 (MLH3) CLIA Kit

20-abx495965 Abbexa
  • 10282.80 EUR
  • 5472.00 EUR
  • 1262.40 EUR
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

MLH1 (untagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 1

SC119993 Origene Technologies GmbH 10 µg Ask for price

MLH1 (untagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 1

SC323792 Origene Technologies GmbH 10 µg Ask for price

Lenti ORF clone of Mlh1 (Myc-DDK-tagged) - Mouse mutL homolog 1 (E. coli) (Mlh1)

MR210511L3 Origene Technologies GmbH 10 µg Ask for price

MLH1 (GFP-tagged) - Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 1

RG201607 Origene Technologies GmbH 10 µg Ask for price

MLH1 (untagged)-Human mutL homolog 1 colon cancer nonpolyposis type 2 (E. coli) (MLH1) transcript variant 3

SC328850 Origene Technologies GmbH 10 µg Ask for price

MLH1 (untagged)-Human mutL homolog 1 colon cancer nonpolyposis type 2 (E. coli) (MLH1) transcript variant 4

SC328851 Origene Technologies GmbH 10 µg Ask for price

MLH1 (untagged)-Human mutL homolog 1 colon cancer nonpolyposis type 2 (E. coli) (MLH1) transcript variant 2

SC329041 Origene Technologies GmbH 10 µg Ask for price

Human MutL Homolog 1 ELISA Kit

IHUMLH1KT Innovative research each 733 EUR
Description: Human MutL Homolog 1 ELISA Kit

Lenti ORF clone of Mlh1 (mGFP-tagged ORF) - Rat mutL homolog 1 (E. coli) (Mlh1), (10 ug)

RR207442L4 Origene Technologies GmbH 10 µg Ask for price

MLH1 (GFP-tagged) - Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 3

RG230212 Origene Technologies GmbH 10 µg Ask for price

MLH1 (GFP-tagged) - Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 4

RG230213 Origene Technologies GmbH 10 µg Ask for price

MLH1 (GFP-tagged) - Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 2

RG230403 Origene Technologies GmbH 10 µg Ask for price

MLH1 (Myc-DDK-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 1

RC201607 Origene Technologies GmbH 10 µg Ask for price

Lenti ORF clone of Mlh1 (Myc-DDK-tagged ORF) - Rat mutL homolog 1 (E. coli) (Mlh1), (10 ug)

RR207442L3 Origene Technologies GmbH 10 µg Ask for price

Lenti ORF particles, Mlh1 (GFP-tagged) - Mouse mutL homolog 1 (E. coli) (Mlh1), 200ul, >10^7 TU/mL

MR210511L4V Origene Technologies GmbH 200 µl Ask for price

MLH1 (Myc-DDK-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 3

RC230212 Origene Technologies GmbH 10 µg Ask for price

MLH1 (Myc-DDK-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 4

RC230213 Origene Technologies GmbH 10 µg Ask for price

MLH1 (Myc-DDK-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 2

RC230403 Origene Technologies GmbH 10 µg Ask for price

Lenti ORF particles, Mlh1 (GFP-tagged ORF) - Rat mutL homolog 1 (E. coli) (Mlh1), 200ul, >10^7 TU/mL

RR207442L4V Origene Technologies GmbH 200 µl Ask for price

Lenti ORF particles, Mlh1 (Myc-DDK-tagged) - Mouse mutL homolog 1 (E. coli) (Mlh1), 200ul, >10^7 TU/mL

MR210511L3V Origene Technologies GmbH 200 µl Ask for price

Lenti ORF particles, Mlh1 (Myc-DDK-tagged ORF) - Rat mutL homolog 1 (E. coli) (Mlh1), 200ul, >10^7 TU/mL

RR207442L3V Origene Technologies GmbH 200 µl Ask for price

MutL Homolog 3 (MLH3) Antibody

abx146077-100ug Abbexa 100 ug 469.2 EUR

MutL Homolog 3 (MLH3) Antibody

20-abx324670 Abbexa
  • 376.80 EUR
  • 292.80 EUR
  • 100 ug
  • 50 ug

MutL Homolog 3 (MLH3) Antibody

abx331047-100ul Abbexa 100 ul 510 EUR

MutL Homolog 3 (MLH3) Antibody

20-abx014047 Abbexa
  • 376.80 EUR
  • 117.60 EUR
  • 477.60 EUR
  • 594.00 EUR
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

MutL Homolog 3 (MLH3) Antibody

abx432972-200ul Abbexa 200 ul 343.2 EUR

MutL Homolog 3 (MLH3) Antibody

20-abx006534 Abbexa
  • 493.20 EUR
  • 710.40 EUR
  • 218.40 EUR
  • 376.80 EUR
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Lenti ORF particles, MLH1 (mGFP-tagged) - Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 1, 200ul,

RC201607L2V Origene Technologies GmbH 200 µl Ask for price

Lenti ORF particles, MLH1 (mGFP-tagged) - Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 1, 200ul,

RC201607L4V Origene Technologies GmbH 200 µl Ask for price

Lenti-ORF clone of MLH1 (mGFP-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 3

RC230212L4 Origene Technologies GmbH 10 µg Ask for price

Lenti-ORF clone of MLH1 (mGFP-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 4

RC230213L4 Origene Technologies GmbH 10 µg Ask for price

Lenti-ORF clone of MLH1 (mGFP-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 2

RC230403L4 Origene Technologies GmbH 10 µg Ask for price

Lenti ORF particles, MLH1 (Myc-DDK tagged) - Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 1, 200u

RC201607L1V Origene Technologies GmbH 200 µl Ask for price

Lenti ORF particles, MLH1 (Myc-DDK tagged) - Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 1, 200u

RC201607L3V Origene Technologies GmbH 200 µl Ask for price

Lenti ORF particles, MLH1 (mGFP-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 3, 200ul, >1

RC230212L4V Origene Technologies GmbH 200 µl Ask for price

Lenti ORF particles, MLH1 (mGFP-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 4, 200ul, >1

RC230213L4V Origene Technologies GmbH 200 µl Ask for price

Lenti ORF particles, MLH1 (mGFP-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 2, 200ul, >1

RC230403L4V Origene Technologies GmbH 200 µl Ask for price

Lenti-ORF clone of MLH1 (Myc-DDK-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 3

RC230212L3 Origene Technologies GmbH 10 µg Ask for price

Lenti-ORF clone of MLH1 (Myc-DDK-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 4

RC230213L3 Origene Technologies GmbH 10 µg Ask for price

Lenti-ORF clone of MLH1 (Myc-DDK-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 2

RC230403L3 Origene Technologies GmbH 10 µg Ask for price

MutL Homolog 3 (MLH3) Magnetic Luminex Assay Kit

LKU606805-96T Biomatik Corporation 96T 1062.6 EUR

MLH3 (untagged)-Human mutL homolog 3 (E. coli) (MLH3), transcript variant 1

SC310948 Origene Technologies GmbH 10 µg Ask for price

Lenti ORF particles, MLH1 (Myc-DDK-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 3, 200ul,

RC230212L3V Origene Technologies GmbH 200 µl Ask for price